Target intelligence / Profile preview

MicroRNA-708 (miR-708)

Target
miR-708
Molecular classification
microRNA, Non-coding RNA, Gene regulator
01

Overview

MicroRNA-708 (miR-708) is a highly conserved, short non-coding RNA molecule located within the first intron of the ODZ4 gene on chromosome 11q14.1. It is widely expressed, with the highest levels in the brain and eyes. MiR-708 primarily acts as a post-transcriptional regulator of gene expression by binding to complementary sequences within the 3′ untranslated regions (3′-UTRs) of target mRNAs, leading to their degradation or translational inhibition. Biologically, miR-708 plays crucial roles in the regulation of cell proliferation, migration, invasion, and apoptosis, including through the modulation of key oncogenic and tumor suppressive pathways. It has been implicated in the pathogenesis of various cancers (such as Ewing's sarcoma, lung, colorectal, ovarian, breast, and prostate cancers), as both a tumor suppressor and, contextually, as an oncogene. MiR-708 also contributes to neural function, stress responses, and metabolic regulation, and its expression or suppression is associated with disease pathogenesis and potential utility as a prognostic biomarker[1][2][3][4][5][6][7][8][9].

Other names
hsa-mir-708MIR708MIRN708miR-708-5pmir-708 microRNAmir-708 precursor
02

Mechanism of action

Function as a tumor suppressor miRNA: Downregulates oncogenes or pro-survival genes by binding to the 3'-UTRs of target mRNAs, resulting in their translational repression or degradation[2][3][5]. Indirect effects on signal transduction pathways (e.g., Akt/mTOR, ERK, Wnt/β-catenin) via target suppression[1][2][5].

03

Biological functions

Regulation of gene expression (post-transcriptional)Cell cycle regulationApoptosisCell proliferationCell migration and invasionStress response (particularly endoplasmic reticulum stress)Angiogenesis regulation
04

Disease associations

Cancer (including Ewing's sarcoma, lung cancer, ovarian cancer, prostate cancer, colorectal cancer, breast cancer, B-cell acute lymphoblastic leukemia, glioblastoma)Neurodegenerative disease (implied via high brain expression and neuronal roles)Metabolic disease (e.g., impaired β-cell function in diabetes)Inflammation (immune signaling via targets like C/EBPβ)
05

Safety considerations

Therapeutic modulation of miR-708 could affect many genes due to its broad regulatory role, posing risk for off-target effects and unanticipated impacts on cell proliferation, apoptosis, and stress response pathways[2][5].Delivery and specificity challenges for miRNA-based therapeutics[2].
06

Interacting drugs

None currently approved or listed as direct interactors. Research compounds or miRNA-mimics/antagomiRs have experimental use but no clinically approved therapies[2][5].
07

Biomarkers

miR-708 expression level is proposed as a biomarker for cancer progression and prognosis (e.g., low miR-708 correlates with poor survival in several cancers)[2][5][7].May serve as a biomarker for neuronal stress or β-cell dysfunction[1][8].

Beyond the preview

Go deeper on MicroRNA-708 (miR-708).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-708 (miR-708).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call